AstraZeneca to buy Amolit Pharma for $1.05bn to boost rare disease portfolio
![](https://4gi.tv/wp-content/uploads/2024/03/1503-ws-he-1024x576.jpg)
Drug maker AstraZeneca said on Thursday it will acquire rare endocrine disease company Amolyt Pharma for $1.05 billion in cash in a bid to boost its rare disease portfolio.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env2.jpg)
Pope Francis calls for action on climate change
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env1.jpg)
Climate change costing Africa up to 5% of GDP, UN says
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env.jpg)
A forest fire has destroyed 20% of the forests in Brazil
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-cul2.jpg)
Toronto Film Festival showcases an industry transformed by streaming
September 6, 2024
LIVE STREAM